Hearing Tests and Spinal Fluid Study in Multiple Sclerosis
Checks hearing and spinal fluid markers in young adults with multiple sclerosis.
Plain-language title generated from the registry record
Registry title: Auditory Functions in Patients With Multiple Sclerosis
Key facts
- Where
- Catania, ItalySee the site
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 20 and 40 years old?
Source: NCT06164483, who can take part
Where in Italy
- Arianna Di StadioCatania, ItalyTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- University of Catania
- Trial code
- NCT06164483
- Record updated
- 12 May 2026
- Original description
The study will analyze the auditory functions of patients with Multiple Sclerosis using auditory tests like pure tone auditory test, speech perception test, Auditory Brain Response (ABR) and Distortion Product Otoacustic Emission (DPOAE). CSF will be collected by lumbar puncture and analyzed looking for inflammatory markers.Read full original descriptionShow less
Electrophysiological Studies of Auditory Functions and CSF Analyses in Patients With Multiple Sclerosis
The study will analyze the auditory functions of patients with Multiple Sclerosis using auditory tests like pure tone auditory test, speech perception test, Auditory Brain Response (ABR) and Distortion Product Otoacustic Emission (DPOAE). CSF will be collected by lumbar puncture and analyzed looking for inflammatory markers.
The results of DPOAE and CSF will be correlated to identify statistically significant correlation.
Inclusion: age >18 and <50,; no history of hearing loss,; no psychiatric condition; no familial history of otosclerosis/deafness/genetic hearing loss; patients with PD and/or MS.
Exclusion: recreational drug consumption; cardiovascular disease non under control; diabetes; hypotensive disorders; epilepsy; stroke < 2 years; Conductive hearing loss; alcohol abuse.